Understanding Pigmentation: Sun Spots, Melasma, and Why They Differ

One of the most common mistakes I see in aesthetic medicine is treating everything brown as though it is the same problem. It is not. A discrete sun spot, diffuse photodamage, post-inflammatory hyperpigmentation, melasma, a raised benign growth, and a medically concerning pigmented lesion can all look brown. Their biology and appropriate treatment are very different.

That distinction matters because pigment treatment is not simply about finding the strongest laser. The wrong treatment, especially in melasma or in skin that is prone to post-inflammatory pigment, can make the condition darker and more difficult to manage.

The first step is diagnosis. The second is understanding why that particular pigment is being produced. Only then does it make sense to choose a topical, light-based, laser, resurfacing, or combination approach.

Melanin is produced by melanocytes, specialized cells located near the base of the epidermis. The melanin is packaged into structures called melanosomes and transferred to surrounding keratinocytes. This pigment helps protect cellular DNA from ultraviolet radiation.

Differences in skin color are influenced less by the number of melanocytes than by how actively they produce melanin, the size and distribution of melanosomes, and how long pigment persists in the skin. That is one reason deeper skin tones can develop more persistent pigment after inflammation.

Melanocytes respond to ultraviolet radiation, visible light, hormones, inflammation, injury, medications, genetics, and local signaling from other cells. Pigment is therefore a biological response, not simply a stain sitting on the surface.

Solar lentigines, commonly called sun spots or age spots, are localized areas of increased pigment associated with cumulative ultraviolet exposure. They tend to have clearer borders and often appear on the face, chest, shoulders, and hands.

Because the pigment is relatively localized, appropriately selected intense pulsed light or pigment-targeting lasers can often improve it. The device has to be matched to the patient's skin type and the depth and character of the lesion. A raised or irregular lesion should not automatically be treated as a cosmetic sun spot without appropriate evaluation.

Removing a visible spot does not erase the ultraviolet exposure that created it. New lesions can appear, and existing ones can recur. Sun protection is therefore part of treatment, not a separate lifestyle suggestion.

Melasma usually appears as broader, often symmetrical patches on sun-exposed areas of the face. It is more common in women and in people with intermediate to deeper skin tones, but it can affect anyone.

Melasma is not simply excess pigment in the epidermis. Research describes a more complex environment involving ultraviolet and visible light exposure, hormonal influence, genetics, inflammation, vascular changes, mast cells, photoaging, and alterations in the basement membrane. This complexity helps explain why melasma behaves differently from a sun spot and why it often returns.

Pregnancy and hormonal medications can be triggers, but a patient does not need an obvious hormonal event to develop melasma. Heat is also reported as a trigger by many patients. The evidence for ultraviolet and visible light is stronger and more consistent than the evidence for heat alone, but practical management often includes reducing repeated heat exposure when the patient recognizes a clear pattern.

Traditional sunscreen discussions focused heavily on ultraviolet A and B. We now understand that visible light can also contribute to persistent pigmentation, particularly in darker skin tones and melasma-prone skin.

Broad-spectrum sunscreen remains foundational. For some patients, a tinted sunscreen containing iron oxides provides additional visible-light protection that a clear sunscreen may not. The best sunscreen is still one the patient will apply generously and repeat consistently, but the formulation can be selected more intelligently when pigmentation is the concern.

Hats, shade, window exposure, and daily habits matter because melasma responds to cumulative stimulation, not only to a day at the beach.

Post-inflammatory hyperpigmentation develops after acne, eczema, a burn, picking, a procedure, or another inflammatory event. The inflammation stimulates pigment production, and in some cases pigment drops more deeply into the dermis, where it clears more slowly.

The first priority is controlling the process that keeps creating inflammation. Treating pigment while active acne, dermatitis, or repeated irritation continues is like mopping the floor while the faucet is still running.

This is also why aggressive procedures must be planned carefully in pigment-prone skin. The procedure intended to remove pigment can create enough inflammation to produce more of it.

A discrete lentigo can be an excellent optical target. We can deliver energy that is preferentially absorbed by the pigment and allow the treated material to clear. Melasma is different because the pigment-producing system remains biologically active. Removing visible pigment does not switch off the system that made it.

Aggressive energy can add heat and inflammation, disrupt the barrier, and provoke rebound pigmentation. Lasers and light devices may still have a role in selected melasma patients, especially as part of a multimodal plan, but they are not first-line magic erasers. Conservative parameters, patient selection, pretreatment, aftercare, and maintenance matter.

A treatment that worked beautifully for a friend's sun spots may be exactly the wrong approach for your melasma.

Topical plans may include ingredients that reduce melanin production, interrupt pigment transfer, increase turnover, reduce inflammation, or support the skin barrier. Hydroquinone remains an important prescription option for selected patients, and non-hydroquinone regimens can also be useful. The correct plan depends on diagnosis, skin sensitivity, pregnancy status, prior treatment, and how long therapy will be used.

More is not always better. Layering several irritating products can create inflammation and worsen pigment. A plan that the skin can tolerate consistently is usually more useful than an aggressive routine the patient abandons after two weeks.

Maintenance is especially important in melasma. Improvement can be substantial, but the tendency to produce pigment remains. Long-term control often requires ongoing light protection and a simpler maintenance regimen after the active phase.

A new, changing, asymmetric, irregular, bleeding, or otherwise concerning pigmented lesion should be medically evaluated rather than treated cosmetically. Cosmetic technology should never be used to make an undiagnosed lesion disappear.

Even benign lesions can require a different approach if they are raised, vascular, or located at a different depth than expected. An accurate examination protects both safety and outcome.

Brown pigment is the visible endpoint of several different biological processes. Sun spots are usually localized photodamage. Melasma is a chronic, light-responsive disorder with multiple contributing pathways. Post-inflammatory pigment is a response to injury. Each requires a different level of caution and a different plan.

The goal is not merely to remove what is visible today. It is to reduce the signals that keep making pigment tomorrow, while avoiding the inflammation that can turn treatment into another trigger.